Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation
Open Access
- 16 December 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (25), 5518-5527
- https://doi.org/10.1182/blood-2009-12-260810
Abstract
Two critical concerns in clinical cord blood transplantation are the initial time to engraftment and the subsequent restoration of immune function. These studies measured the impact of progenitor cell dose on both the pace and strength of hematopoietic reconstitution by transplanting nonobese diabetic/severe combined immunodeficiency/interleukin-2 receptor-gamma–null (NSγ) mice with lineage-depleted aldehyde dehydrogenase-bright CD34+ human cord blood progenitors. The progress of each transplant was monitored over an extended time course by repeatedly analyzing the peripheral blood for human hematopoietic cells. In vivo human hematopoietic development was complete. After long-term transplantation assays (≥ 19 weeks), human T-cell development was documented within multiple tissues in 16 of 32 NSγ mice. Human T-cell differentiation was active within NSγ thymuses, as documented by the presence of CD4+ CD8+ T-cell progenitors as well as T-cell receptor excision circles. It is important to note that although myeloid and B-cell engraftment was detected as early as 4 weeks after transplantation, human T-cell development was exclusively late onset. High progenitor cell doses were associated with a robust human hematopoietic chimerism that accelerated both initial time to engraftment and subsequent T-cell development. At lower progenitor cell doses, the chimerism was weak and the human hematopoietic lineage development was frequently incomplete.Keywords
This publication has 46 references indexed in Scilit:
- An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftmentBlood, 2010
- Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2Rγ Null MiceThe International Journal of Cell Cloning, 2009
- In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord bloodNature Protocols, 2008
- Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomesBlood, 2008
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- Protection against LethalAspergillus fumigatusInfection in Mice by Allogeneic Myeloid Progenitors Is Not Major Histocompatibility Complex RestrictedThe Journal of Infectious Diseases, 2005
- Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropeniaBlood, 2005
- Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantationBlood, 2003
- Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantationBritish Journal of Haematology, 2003
- The number and generative capacity of human B lymphocyte progenitors, measured in vitro and in vivo, is higher in umbilical cord blood than in adult or pediatric bone marrowBone Marrow Transplantation, 1999